FDA Deciding Fate of Genetically Engineered Salmon

On Tuesday, the US Food and Drug Administration resumed the functions of the hearing for the approval of the genetically altered salmon, as a food supply for people. This hearing lasted for two days with the FDA’s advisers discussing the reasons why the consumers should be warned against the fish and the fact that it was genetically modified.

The hearing was intended to collect the opinions of the public consumers on the type of information that they would prefer to see on the food label and whether it is important for them to know that this fish is actually genetically modified or not.

According to AquaBounty Technologies Incorporation, the food supplier of the controversial salmon, as long as the FDA and its advisers examined the fish, proved that it is safe for the public use, then there is the point in adding a label that would say that this fish has been genetically engineered.

In the meantime, the FDA’s main concern was to make sure this salmon is entirely safe for the people and pose no risk on the environment. In case approved, AquaBounty’s salmon would be the first genetically modified food animal in the country.

Michael Landa, the Acting Director of the FDA's Center for Food Safety and Applied Nutrition, said, "We're presenting an opportunity for people to explain to us if there are material differences, [and] if so, what they are and how they might be disclosed".